{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:05:38Z","timestamp":1784394338834,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005289","name":"National Institute of Justice","doi-asserted-by":"publisher","award":["2020-DQ-BX-0007"],"award-info":[{"award-number":["2020-DQ-BX-0007"]}],"id":[{"id":"10.13039\/100005289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA 000523-13"],"award-info":[{"award-number":["DA 000523-13"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00213-022-06292-5","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:27:56Z","timestamp":1671251276000},"page":"185-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats"],"prefix":"10.1007","volume":"240","author":[{"given":"Sara E.","family":"Walton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-1882","authenticated-orcid":false,"given":"Alex J.","family":"Krotulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Glatfelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry K.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"6292_CR1","unstructured":"AAFS Standards Board (20219)\u00a0Standard practices for method validation in forensic toxicology. https:\/\/www.aafs.org\/sites\/default\/files\/media\/documents\/036_Std_e1.pdf"},{"key":"6292_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00414-021-02729-2","volume":"136","author":"P Adamowicz","year":"2022","unstructured":"Adamowicz P, Nowak K (2022) Blood concentrations of new synthetic opioids. Int J Legal Med 136:107\u2013122. https:\/\/doi.org\/10.1007\/s00414-021-02729-2","journal-title":"Int J Legal Med"},{"key":"6292_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev.pa.28.040188.002241","volume":"28","author":"MW Adler","year":"1988","unstructured":"Adler MW, Geller EB, Rosow CE, Cochin J (1988) The opioid system and temperature regulation. Annu Rev Pharmacol Toxicol 28:429\u2013449. https:\/\/doi.org\/10.1146\/annurev.pa.28.040188.002241","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"6292_CR4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.tips.2018.09.006","volume":"39","author":"MH Baumann","year":"2018","unstructured":"Baumann MH, Kopajtic TA, Madras BK (2018) Pharmacological research as a key component in mitigating the opioid overdose crisis. Trends Pharmacol Sci 39:995\u2013998. https:\/\/doi.org\/10.1016\/j.tips.2018.09.006","journal-title":"Trends Pharmacol Sci"},{"key":"6292_CR5","doi-asserted-by":"publisher","first-page":"E895","DOI":"10.3390\/brainsci10110895","volume":"10","author":"MH Baumann","year":"2020","unstructured":"Baumann MH, Tocco G, Papsun DM, Mohr AL, Fogarty MF, Krotulski AJ (2020) U-47700 and its analogs: non-fentanyl synthetic opioids impacting the recreational drug market. Brain Sci 10:E895. https:\/\/doi.org\/10.3390\/brainsci10110895","journal-title":"Brain Sci"},{"key":"6292_CR6","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1007\/s00213-021-05981-x","volume":"238","author":"MS-S Bergh","year":"2021","unstructured":"Bergh MS-S, Bogen IL, Garibay N, Baumann MH (2021) Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats. Psychopharmacology 238:3629\u20133641. https:\/\/doi.org\/10.1007\/s00213-021-05981-x","journal-title":"Psychopharmacology"},{"key":"6292_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/dta.2738","volume":"12","author":"P Blanckaert","year":"2020","unstructured":"Blanckaert P, Cannaert A, Van Uytfanghe K, Hulpia F, Deconinck E, Van Calenbergh S, Stove C (2020) Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene. Drug Test Anal 12:422\u2013430. https:\/\/doi.org\/10.1002\/dta.2738","journal-title":"Drug Test Anal"},{"key":"6292_CR8","doi-asserted-by":"publisher","unstructured":"Bowdle TA (1998) Adverse effects of opioid agonists and agonist-antagonists in anaesthesia: drug safety. 19:173\u2013189.https:\/\/doi.org\/10.2165\/00002018-199819030-00002","DOI":"10.2165\/00002018-199819030-00002"},{"key":"6292_CR9","doi-asserted-by":"publisher","first-page":"109263","DOI":"10.1016\/j.neuropharm.2022.109263","volume":"221","author":"MA De Luca","year":"2022","unstructured":"De Luca MA, Tocco G, Mostallino R, Laus A, Caria F, Musa A, Pintori N, Ucha M, Poza C, Ambrosio E, Di Chiara G, Castelli MP (2022) Pharmacological characterization of novel synthetic opioids: isotonitazene, metonitazene, and piperidylthiambutene as potent \u03bc-opioid receptor agonists. Neuropharmacology 221:109263. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109263","journal-title":"Neuropharmacology"},{"key":"6292_CR10","unstructured":"Drug Enforcement Administration (2020) Temporary placement of isotonitazene in schedule I. URL https:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2020\/fr0618.htm (accessed 11.2.20)."},{"key":"6292_CR11","unstructured":"Drug Enforcement Administration (2021) Schedules of controlled substances: temporary placement of butonitazene, etodesnitazene, flunitazene, metodesnitazene, metonitazene, N-pyrrolidino etonitazene, and protonitazene in schedule I. Federal Register. URL https:\/\/www.federalregister.gov\/documents\/2021\/12\/07\/2021-26263\/schedules-of-controlled-substances-temporary-placement-of-butonitazene-etodesnitazene-flunitazene?mc_cid=d9b4770794&mc_eid=a5414db336 (accessed 12.14.21)"},{"key":"#cr-split#-6292_CR12.1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2020) Risk assessment report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1ethanamine (isotonitazene) in accordance with Article 5c of Regulation"},{"key":"#cr-split#-6292_CR12.2","unstructured":"(EC) No 1920\/2006 (as amended), Risk Assessments, Publications Office of the European Union, Luxembourg. https:\/\/www.emcdda.europa.eu\/publications\/initial-reports\/isotonitazene_en"},{"key":"6292_CR13","first-page":"391","volume":"225","author":"EB Geller","year":"1983","unstructured":"Geller EB, Hawk C, Keinath SH, Tallarida RJ, Adler MW (1983) Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration. J Pharmacol Exp Ther 225:391\u2013398","journal-title":"J Pharmacol Exp Ther"},{"key":"6292_CR14","unstructured":"Hoffman K, Hunger A, Kebrle J, Rossi A (1960) Benzimidazoles, United States Patent Office. https:\/\/patents.google.com\/patent\/US2935514A\/en"},{"key":"6292_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/BF02161116","volume":"13","author":"A Hunger","year":"1957","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K (1957) Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate. Experientia 13:400\u2013401. https:\/\/doi.org\/10.1007\/BF02161116","journal-title":"Experientia"},{"key":"6292_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/hlca.19600430323","volume":"43","author":"A Hunger","year":"1960","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K (1960) Benzimidazol-Derivate und verwandte Heterocyclen. II. Synthese von 1-Aminoalkyl-2-benzyl-benzimidazolen. Helv Chim Acta 43:800\u2013809. https:\/\/doi.org\/10.1002\/hlca.19600430323","journal-title":"Helv Chim Acta"},{"key":"6292_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/jat\/bkaa016","volume":"44","author":"AJ Krotulski","year":"2020","unstructured":"Krotulski AJ, Papsun DM, Kacinko SL, Logan BK (2020) Isotonitazene quantitation and metabolite discovery in authentic forensic casework. J Anal Toxicol 44:521\u2013530. https:\/\/doi.org\/10.1093\/jat\/bkaa016","journal-title":"J Anal Toxicol"},{"key":"6292_CR18","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/dta.3115","volume":"13","author":"AJ Krotulski","year":"2021","unstructured":"Krotulski AJ, Papsun DM, Walton SE, Logan BK (2021) Metonitazene in the United States\u2014forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry. Drug Test Anal 13:1697\u20131711. https:\/\/doi.org\/10.1002\/dta.3115","journal-title":"Drug Test Anal"},{"key":"6292_CR19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01967","author":"JC Lee","year":"2022","unstructured":"Lee JC, Park H, Eubanks LM, Ellis B, Zhou B, Janda KD (2022) A Vaccine against benzimidazole-derived new psychoactive substances that are more potent than fentanyl. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01967","journal-title":"J Med Chem"},{"key":"6292_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0304-3940(82)90273-7","volume":"32","author":"GS Ling","year":"1982","unstructured":"Ling GS, Pasternak GW (1982) Morphine catalepsy in the rat: involvement of mu 1 (high affinity) opioid binding sites. Neurosci Lett 32:193\u2013196. https:\/\/doi.org\/10.1016\/0304-3940(82)90273-7","journal-title":"Neurosci Lett"},{"key":"6292_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000970","author":"E Montanari","year":"2022","unstructured":"Montanari E, Madeo G, Pichini S, Busard\u00f2 FP, Carlier J (2022) Acute Intoxications and fatalities associated with benzimidazole opioid (nitazene analog) use: a systematic review. Ther Drug Monit. https:\/\/doi.org\/10.1097\/FTD.0000000000000970","journal-title":"Ther Drug Monit"},{"key":"6292_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bky049","volume":"43","author":"JB Morrow","year":"2019","unstructured":"Morrow JB, Ropero-Miller JD, Catlin ML, Winokur AD, Cadwallader AB, Staymates JL, Williams SR, McGrath JG, Logan BK, McCormick MM, Nolte KB, Gilson TP, Menendez MJ, Goldberger BA (2019) The opioid epidemic: moving toward an integrated, holistic analytical response. J Anal Toxicol 43:1\u20139. https:\/\/doi.org\/10.1093\/jat\/bky049","journal-title":"J Anal Toxicol"},{"key":"6292_CR23","doi-asserted-by":"publisher","first-page":"110686","DOI":"10.1016\/j.forsciint.2021.110686","volume":"320","author":"F Mueller","year":"2021","unstructured":"Mueller F, Bogdal C, Pfeiffer B, Andrello L, Ceschi A, Thomas A, Grata E (2021) Isotonitazene: fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland. Forensic Sci Int 320:110686. https:\/\/doi.org\/10.1016\/j.forsciint.2021.110686","journal-title":"Forensic Sci Int"},{"key":"6292_CR24","unstructured":"NPS Discovery (2021a) Q3 2021a Opioid trend report. URL\u00a0https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2021\/10\/2021-Q3_NPS-Opioids_Trend-Report.pdf (accessed 12.14.21)"},{"key":"6292_CR25","unstructured":"NPS Discovery (2021b) N-Pyrrolidino-Etonitazene monograph. URL https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2021b\/05\/N-Pyrrolidino-Etonitazene_051321_ToxicologyAnalyticalReport.pdf (accessed 7.28.21)"},{"key":"6292_CR26","unstructured":"NPS Discovery (2021c) Public alert: N-pyrrolidino etonitazene. URL https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2021c\/06\/Public-Alert_N-Pyrrolidino-Etonitazene_NPS-Discovery_061721.pdf (accessed 1.28.22)"},{"key":"6292_CR27","doi-asserted-by":"publisher","DOI":"10.7249\/RR3116","author":"B Pardo","year":"2019","unstructured":"Pardo B, Caulkins J, Kilmer B, Pacula R, Reuter P, Stein B (2019) The synthetic opioid surge in the United States: insights from mortality and seizure data. RAND Corporation. https:\/\/doi.org\/10.7249\/RR3116","journal-title":"RAND Corporation"},{"issue":"Suppl 1","key":"6292_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0024-3205(83)90470-8","volume":"33","author":"GW Pasternak","year":"1983","unstructured":"Pasternak GW, Gintzler AR, Houghten RA, Ling GS, Goodman RR, Spiegel K, Nishimura S, Johnson N, Recht LD (1983) Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system. Life Sci 33(Suppl 1):167\u2013173. https:\/\/doi.org\/10.1016\/0024-3205(83)90470-8","journal-title":"Life Sci"},{"key":"6292_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40122-017-0068-3","volume":"6","author":"JV Pergolizzi","year":"2017","unstructured":"Pergolizzi JV, LeQuang JA, Berger GK, Raffa RB (2017) The basic pharmacology of opioids informs the opioid discourse about misuse and abuse: a review. Pain Ther 6:1\u201316. https:\/\/doi.org\/10.1007\/s40122-017-0068-3","journal-title":"Pain Ther"},{"key":"6292_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-0773.1992.tb00441.x","volume":"70","author":"R P\u00f6yhi\u00e4","year":"1992","unstructured":"P\u00f6yhi\u00e4 R, Kalso EA (1992) Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats. Pharmacol Toxicol 70:125\u2013130. https:\/\/doi.org\/10.1111\/j.1600-0773.1992.tb00441.x","journal-title":"Pharmacol Toxicol"},{"key":"6292_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","volume":"11","author":"MP Prekupec","year":"2017","unstructured":"Prekupec MP, Mansky PA, Baumann MH (2017) Misuse of novel synthetic opioids: a deadly new trend. J Addict Med 11:256\u2013265. https:\/\/doi.org\/10.1097\/ADM.0000000000000324","journal-title":"J Addict Med"},{"key":"6292_CR32","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2741\/190","volume":"3","author":"SM Rawls","year":"2011","unstructured":"Rawls SM, Benamar K (2011) Effects of opioids, cannabinoids, and vanilloids on body temperature. Front Biosci (schol Ed) 3:822\u2013845. https:\/\/doi.org\/10.2741\/190","journal-title":"Front Biosci (schol Ed)"},{"key":"6292_CR33","doi-asserted-by":"publisher","first-page":"113778","DOI":"10.1016\/j.expneurol.2021.113778","volume":"343","author":"D Rudin","year":"2021","unstructured":"Rudin D, Liechti ME, Luethi D (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Exp Neurol 343:113778. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113778","journal-title":"Exp Neurol"},{"key":"6292_CR34","doi-asserted-by":"publisher","unstructured":"Shover CL, Falasinnu TO, Freedman RB, Humphreys K (2021) Emerging characteristics of isotonitazene-involved overdose deaths: a case-control study. Journal of Addiction Medicine Publish Ahead of Print. https:\/\/doi.org\/10.1097\/ADM.0000000000000775","DOI":"10.1097\/ADM.0000000000000775"},{"key":"6292_CR35","doi-asserted-by":"publisher","unstructured":"Solimini R, Pichini S, Pacifici R, Busard\u00f2 FP, Giorgetti R (2018) Pharmacotoxicology of non-fentanyl derived new synthetic opioids. Front Pharmacol 9.https:\/\/doi.org\/10.3389\/fphar.2018.00654","DOI":"10.3389\/fphar.2018.00654"},{"key":"6292_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/s1734-1140(09)70083-0","volume":"61","author":"E Taracha","year":"2009","unstructured":"Taracha E, Mierzejewski P, Lehner M, Chrapusta SJ, Ka\u0142a M, Lechowicz W, Hamed A, Sk\u00f3rzewska A, Kostowski W, P\u0142a\u017anik A (2009) Stress-opioid interactions: a comparison of morphine and methadone. Pharmacol Rep 61:424\u2013435. https:\/\/doi.org\/10.1016\/s1734-1140(09)70083-0","journal-title":"Pharmacol Rep"},{"key":"6292_CR37","doi-asserted-by":"crossref","unstructured":"Trescot AM, Datta S, Lee M, Hansen H (2008) Opioid pharmacology. Pain Physician S133\u2013S153. https:\/\/www.painphysicianjournal.com\/current\/pdf?article=OTg3&journal=42","DOI":"10.36076\/ppj.2008\/11\/S133"},{"key":"6292_CR38","doi-asserted-by":"publisher","first-page":"108195","DOI":"10.1016\/j.neuropharm.2020.108195","volume":"177","author":"MT Truver","year":"2020","unstructured":"Truver MT, Smith CR, Garibay N, Kopajtic TA, Swortwood MJ, Baumann MH (2020) Pharmacodynamics and pharmacokinetics of the novel synthetic opioid, U-47700, in male rats. Neuropharmacology 177:108195. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108195","journal-title":"Neuropharmacology"},{"key":"6292_CR39","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1021\/acschemneuro.1c00037","volume":"12","author":"I Ujv\u00e1ry","year":"2021","unstructured":"Ujv\u00e1ry I, Christie R, Evans-Brown M, Gallegos A, Jorge R, de Morais J, Sedefov R (2021) DARK classics in chemical neuroscience: etonitazene and related benzimidazoles. ACS Chem Neurosci 12:1072\u20131092. https:\/\/doi.org\/10.1021\/acschemneuro.1c00037","journal-title":"ACS Chem Neurosci"},{"key":"6292_CR40","unstructured":"Upadhyay P (2021) Novel psychoactive substances: testing challenges and strategies. Clinical Lab Manager. URL https:\/\/www.clinicallabmanager.com\/trends\/drug-testing\/novel-psychoactive-substances-testing-challenges-and-strategies-26051 (accessed 12.14.21)"},{"key":"6292_CR41","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1021\/acschemneuro.1c00064","volume":"12","author":"MM Vandeputte","year":"2021","unstructured":"Vandeputte MM, Van Uytfanghe K, Layle NK, St. Germaine DM, Lula DM, Stove CP (2021) Synthesis, chemical characterization, and \u03bc-opioid receptor activity assessment of the emerging group of \u201cnitazene\u201d 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci 12:1241\u20131251. https:\/\/doi.org\/10.1021\/acschemneuro.1c00064","journal-title":"ACS Chem Neurosci"},{"key":"6292_CR42","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00204-022-03276-4","volume":"96","author":"MM Vandeputte","year":"2022","unstructured":"Vandeputte MM, Krotulski AJ, Walther D, Glatfelter GC, Papsun D, Walton SE, Logan BK, Baumann MH, Stove CP (2022) Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole \u201cnitazene\u201d synthetic opioid. Arch Toxicol 96:1845\u20131863. https:\/\/doi.org\/10.1007\/s00204-022-03276-4","journal-title":"Arch Toxicol"},{"key":"6292_CR43","doi-asserted-by":"publisher","unstructured":"Vandeputte MM, Krotulski AJ, Papsun DM, Logan BK, Stove CP (2021a) The rise and fall of isotonitazene and brorphine: two recent stars in the synthetic opioid firmament. J Anal Toxicol bkab082. https:\/\/doi.org\/10.1093\/jat\/bkab082","DOI":"10.1093\/jat\/bkab082"},{"key":"6292_CR44","doi-asserted-by":"publisher","unstructured":"Walton SE, Krotulski AJ, Logan BK (2021) A forward-thinking approach to addressing the new synthetic opioid 2-benzylbenzimidazole nitazene analogs by liquid chromatography\u2013tandem quadrupole mass spectrometry (LC\u2013QQQ-MS). J Anal Toxicol bkab117. https:\/\/doi.org\/10.1093\/jat\/bkab117","DOI":"10.1093\/jat\/bkab117"},{"key":"6292_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/08958378.2017.1282065","volume":"29","author":"B Wong","year":"2017","unstructured":"Wong B, Perkins MW, Tressler J, Rodriguez A, Devorak J, Sciuto AM (2017) Effects of inhaled aerosolized carfentanil on real-time physiological responses in mice: a preliminary evaluation of naloxone. Inhal Toxicol 29:65\u201374. https:\/\/doi.org\/10.1080\/08958378.2017.1282065","journal-title":"Inhal Toxicol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06292-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T01:03:12Z","timestamp":1673226192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06292-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6292"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06292-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}